Back
ESC2025 Premium Access

Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis

Session: New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders
Topic: Valvular Heart Disease
Speaker: Doctor M. Al Zaidi (Bonn, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Muntadher Al Zaidi

University hospital Bonn, Bonn (Germany)
0 follower

9 more presentations in this session

Discussant - Biomarkers, biomechanics, and innovations in valve and vascular disorders

Access
Like
Thumbnail

Benefits of extubation after the Fontan operation: a theoretical analysis using serial patient-specific Fontan computational fluid dynamics models

Speaker: Doctor K. Sughimoto (Chiba, JP)

Access
Abstract
Video
Like
Thumbnail

GPER1 as a predictive biomarker for maternal SSA/SSB antibody-associated fetal cardiac abnormalities

Speaker: Professor Y. He (Beijing, CN)

Access
Abstract
Video
Like
Thumbnail

Factors that increase the risk of hepatocarcinoma in Fontan-associated liver disease (FALD) and new biomarkers of FALD by proteomic analysis

Speaker: Doctor Y. Morimoto (Barcelona, ES)

Access
Abstract
Video
Like
Thumbnail

Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk

Speaker: Ms K. Lee (Singapore, SG)

Access
Abstract
Like
Thumbnail

Access the full session

New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders

Speakers: Doctor M. Al Zaidi, Doctor K. Sughimoto, Professor Y. He, Doctor Y. Morimoto, Ms K. Lee
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources